Uganda
In Uganda EQUIP has completed budget costing and impact modelling of the Test & Start policy and the results were accepted for Poster Presentation at the July 2017 International AIDS Society (IAS) Conference held in Paris. Moving forward to the next phase, EQUIP’s focus area in Uganda will centre around providing a cost-outcomes evaluation of the differentiated models of antiretroviral therapy (ART) service delivery. This phase is primarily aimed at the UNAIDS third 90; helping 90% of all people receiving ART in Uganda achieve viral suppression.
Our Consortium Partners
- HE2RO
- Right to Care
Our Supporting Partners
- Boston University
Population
- 41 Million
GDP in 2016
- $25.53 Billion USD